BIOREM Reports First Quarter 2019 Financial Results

About this update from Biorem Inc.

[{"type":"text","content":"\n\n\n\nBIOREM Reports First Quarter 2019 Financial Results\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 1pt solid; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.67em\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 1pt solid; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prngen7{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 1pt solid; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnsbb0{\nBORDER-BOTTOM:0pt\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prnsbr0{\nBORDER-RIGHT:0pt\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnsbbs{\nBORDER-BOTTOM:black 1pt solid\n}\n.prnsbl0{\nBORDER-LEFT:0pt\n}\n.prnsblb0{\nBORDER-LEFT:black 0pt\n}\n.prnrbrb0{\nBORDER-RIGHT:black 0pt\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n.prnpr8{\nPADDING-RIGHT:0.67em\n}\n.prnsbt0{\nBORDER-TOP:0pt\n}\n.prnsbtb0{\nBORDER-TOP:black 0pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n\n\n\n\n\n\n\nCanada NewsWire\nGUELPH, ON, May 29, 2019\n\n\n\nGUELPH, ON, May 29, 2019 /CNW/ - BIOREM Inc. (TSX-V: BRM) (\"Biorem\" or \"the Company\") today announced results for the three month period ended March 31, 2019.  Biorem's complete 2019 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).\nFinancial Summary:\nThree-months ended\nMarch 31,\nDecember 31\n( in CDN$'000 except per share data)\n2019\n2018\n2018\nRevenue\n4,061\n3,883\n10,871\nGross profit\n704\n815\n3,393\nEbitda*\n(96)\n(165)\n1,412\nNet earnings (loss)\n(119)\n(169)\n4,334\nBasic earnings per share\n0.00\n0.00\n0.11\nDiluted earnings per share\n0.00\n0.00\n0.11\n*Earnings before interest, taxes and amortization, a non IFRS financial measure\n \nRevenues for the quarter totalled $4.1 million a $178,000 or 4.6% increase from revenues of $3.9 ...

More updates from Biorem Inc.